PROVIDER PROFILE · NPI 1942646393
Shermin RutherfordP.A.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,163
Unique beneficiaries
—
Total services
70,131
Distinct HCPCS
21
Medicare payment
$283K
PRESCRIBING · PART D · 2024
Total Rx claims
2,520
Beneficiaries
—
Total drug cost
$513K
Distinct drugs
32
Brand share
38.1%
Top prescribed drugs
Tamsulosin Hcl447 claims
Mirabegron250 claims
Finasteride192 claims
Nitrofurantoin Monohyd/M-Cryst170 claims
Sulfamethoxazole/Trimethoprim157 claims
QUALITY · MIPS · 2024
Final MIPS score
99.2
Quality
0.0
Cost
79.5
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
1.02%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
69
By payment type
Food and Beverage$2K
Top paying entities
Food and Beverage$2K
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
REFERRAL NETWORK
Where Shermin Rutherford's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Pacific Point Laboratories, Inc. Clinical Laboratory · San Luis Obispo, CA | 26 | 55 |
| Craig Canfield Urology · San Luis Obispo, CA | 12 | 22 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE